Equity Analysis

Quarterly Results

    Cipla Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    500087
    INE059A01026
    360.7464513
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    CIPLA
    30.54
    129316.22
    EPS(TTM)
    Face Value()
    Div & Yield %:
    52.43
    2
    0.81
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales3969.863752.253444.92
Other Operating Income805.17748.80591.74
Other Income 289.14213.52594.98
Total Income5064.174714.574631.64
Total Expenditure 3336.993141.193208.77
PBIDT1727.181573.381422.87
Interest 3.005.075.45
PBDT1724.181568.311417.42
Depreciation145.71137.86136.81
Tax406.73357.92240.18
Fringe Benefit Tax0.000.000.00
Deferred Tax-6.4216.592.03
Reported Profit After Tax1178.161055.941038.40
Extra-ordinary Items 0.000.0056.37
Adjusted Profit After Extra-ordinary item1178.161055.94982.03
EPS (Unit Curr.)14.5913.0812.86
EPS (Adj) (Unit Curr.)14.5913.0812.86
Calculated EPS (Unit Curr.)14.5913.0812.86
Calculated EPS (Adj) (Unit Curr.)14.5913.0812.86
Calculated EPS (Ann.) (Unit Curr.)58.3652.3151.45
Calculated EPS (Adj) (Ann.) (Unit Curr.)58.3652.3151.45
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.00650.00
Equity161.51161.50161.47
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)43.5141.9341.30
PBDTM(%)43.4341.8041.15
PATM(%)29.6828.1430.14
Dividend Per Share(Rs)0.000.0013.00
Diluted EPS14.4813.0712.85